These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 32786121)
21. De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis. Heo KS; Chang E; Le NT; Cushman H; Yeh ET; Fujiwara K; Abe J Circ Res; 2013 Mar; 112(6):911-23. PubMed ID: 23381569 [TBL] [Abstract][Full Text] [Related]
22. SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer. Wei M; Huang X; Liao L; Tian Y; Zheng X Cancer Res; 2023 Sep; 83(17):2908-2923. PubMed ID: 37350666 [TBL] [Abstract][Full Text] [Related]
23. MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape. Lemma RB; Ledsaak M; Fuglerud BM; Rodríguez-Castañeda F; Eskeland R; Gabrielsen OS J Biol Chem; 2023 Sep; 299(9):105062. PubMed ID: 37468105 [TBL] [Abstract][Full Text] [Related]
24. The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression. Rodríguez-Castañeda F; Lemma RB; Cuervo I; Bengtsen M; Moen LM; Ledsaak M; Eskeland R; Gabrielsen OS J Biol Chem; 2018 Oct; 293(40):15439-15454. PubMed ID: 30082317 [TBL] [Abstract][Full Text] [Related]
25. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene. Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139 [TBL] [Abstract][Full Text] [Related]
26. SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML. Fasci D; Anania VG; Lill JR; Salvesen GS Sci Signal; 2015 Jun; 8(380):ra56. PubMed ID: 26060329 [TBL] [Abstract][Full Text] [Related]
27. SENP1 mediates TNF-induced desumoylation and cytoplasmic translocation of HIPK1 to enhance ASK1-dependent apoptosis. Li X; Luo Y; Yu L; Lin Y; Luo D; Zhang H; He Y; Kim YO; Kim Y; Tang S; Min W Cell Death Differ; 2008 Apr; 15(4):739-50. PubMed ID: 18219322 [TBL] [Abstract][Full Text] [Related]
28. The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation. Nishida T; Yamada Y Biochem Biophys Res Commun; 2011 Mar; 406(2):285-91. PubMed ID: 21316347 [TBL] [Abstract][Full Text] [Related]
29. Exploring the desumoylation process of SENP1: a study combined MD simulations with QM/MM calculations on SENP1-SUMO1-RanGAP1. Shi T; Han Y; Li W; Zhao Y; Liu Y; Huang Z; Lu S; Zhang J J Chem Inf Model; 2013 Sep; 53(9):2360-8. PubMed ID: 23930863 [TBL] [Abstract][Full Text] [Related]
30. SUMO-specific protease 2 in Mdm2-mediated regulation of p53. Jiang M; Chiu SY; Hsu W Cell Death Differ; 2011 Jun; 18(6):1005-15. PubMed ID: 21183956 [TBL] [Abstract][Full Text] [Related]
31. SENP1-mediated GATA1 deSUMOylation is critical for definitive erythropoiesis. Yu L; Ji W; Zhang H; Renda MJ; He Y; Lin S; Cheng EC; Chen H; Krause DS; Min W J Exp Med; 2010 Jun; 207(6):1183-95. PubMed ID: 20457756 [TBL] [Abstract][Full Text] [Related]
32. SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human islets. Hajmrle C; Ferdaoussi M; Plummer G; Spigelman AF; Lai K; Manning Fox JE; MacDonald PE Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E664-73. PubMed ID: 25139051 [TBL] [Abstract][Full Text] [Related]
33. Sentrin/SUMO specific proteases as novel tissue-selective modulators of vitamin D receptor-mediated signaling. Lee WP; Jena S; Doherty D; Ventakesh J; Schimdt J; Furmick J; Widener T; Lemau J; Jurutka PW; Thompson PD PLoS One; 2014; 9(2):e89506. PubMed ID: 24586832 [TBL] [Abstract][Full Text] [Related]
34. SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans. Dai XQ; Plummer G; Casimir M; Kang Y; Hajmrle C; Gaisano HY; Manning Fox JE; MacDonald PE Diabetes; 2011 Mar; 60(3):838-47. PubMed ID: 21266332 [TBL] [Abstract][Full Text] [Related]
35. Regulation of post-translational modification in breast cancer treatment. Heo KS BMB Rep; 2019 Feb; 52(2):113-118. PubMed ID: 30638182 [TBL] [Abstract][Full Text] [Related]
37. Progress in the Discovery of Small Molecule Modulators of DeSUMOylation. Chen S; Dong D; Xin W; Zhou H Curr Issues Mol Biol; 2020; 35():17-34. PubMed ID: 31422931 [TBL] [Abstract][Full Text] [Related]
38. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53. Lin JY; Ohshima T; Shimotohno K FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968 [TBL] [Abstract][Full Text] [Related]
39. The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction. Ohbayashi N; Kawakami S; Muromoto R; Togi S; Ikeda O; Kamitani S; Sekine Y; Honjoh T; Matsuda T Biochem Biophys Res Commun; 2008 Jul; 371(4):823-8. PubMed ID: 18474224 [TBL] [Abstract][Full Text] [Related]